to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Is venture capital still viable as a model for funding new bioscience research, products and businesses?
Investors in bioscience are looking not just for financial returns, but societal returns over the long haul in a global economy. And that will take collaborative efforts and a crowdsourcing of expertise as well as capital.
With only three quarters completed, 2013 has already been a record year for venture funding in digital health, according to San Francisco-based health IT incubator Rock Health, which has been tracking deals in the space since 2011.
Crowdfunding is a hot topic in the entrepreneurship space these days. Many startups are asking about it, and are trying to decide if seeking funding from the crowd is the right for their company. Sensing this demand, we hosted a three hour event on the subject a few days ago which you can view here and here.
On Aug. 27, we are welcoming Slava Rubin, the CEO of Indiegogo, one of the most-successful and most-recognized crowdfunding platforms, to the Kauffman Foundation. We expect a full crowd for this event, but we also will be showing his presentation entitled “How to Raise $1Million in 30 Days or Less” on a live stream that can be found here.
One of the questions I get asked the most is some version of "what do you think of crowdfunding?" I usually answer with some noncommittal answer about how it is going to be important, but no really knows how it will impact the trajectory and success of startup companies. After all, the notion of banding together through social media to fund the development of a prototype, documentary film or art project has been going on for many years now.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.